Free Daily Podcast Summary
Business Of Biotech: Daily Summaries Delivered
by Ben Comer
The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, regulatory, and commercial challenges you’ll face as you navigate your company from an idea to success in the clinic and beyond. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries.
Latest Episodes
The most recent episodes — sign up to get AI-powered summaries of each one.
- 6 days ago55 min
Biotech Finance And Investor Update With Independent Board Director Allan Shaw
We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Independent Board Director and five-time public company CFO Alan Shaw returns to the show for an update on current biotech financing and the strategies needed to secure capital now. Allan explains how biotech investors price risk as the market opens back up, the importance of valuation discipline, and the financing choices that separate “available capital” from “accessible capital.” Alla...
- 1 weeks ago55 min
Funding A Virtual Biotech Without Institutional Capital With Sarcomatrix's David Craig
We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, David Craig, Cofounder, President, and CEO at Sarcomatrix, explains why the old biotech playbook breaks down in today’s funding environment and what it takes to build a lean virtual drug development company without institutional financing. Craig describes practical financing paths, hard truths about costs, and the tradeoffs that make a rare disease program investable through alternative ...
- 2 weeks ago58 min
Picking Biotech Winners Beyond The Hype Cycle With Andera Partners' Olivier Litzka
We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Olivier Litzka, Partner at Andera Partners, talks about what it really takes for biotech companies to attract capital, stay focused, and survive the moments when biology and execution punch back. Olivia also discusses a collaborative effort in Europe to create a stronger public market and investor base, and what the emergence of AI and Chinese biotech means for building tomorrow's biotec...
- 3 weeks ago56 min
Biotech Investing At The Earliest Stages With Santé Ventures' Omar Khalil
We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Omar Khalil, Managing Director at Santé Ventures, describes forming and funding startups and early-stage biotech companies with a focus on clinical data and differentiation as the key value drivers. Omar talks about his interest in 'undruggable targets,' what's happening with the IPO market, an investor shift from biology risk to commercial risk, and building companies through a ve...
- Aug 17, 202650 min
Getting To A First Product Approval With Celcuity's Brian Sullivan
We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Brian Sullivan, CEO at Celcuity, talks about winning the company's first FDA approval for Revtorpyk, a kinase inhibitor for breast cancer patients, and why targeting an “untreated disease mechanism” can beat chasing a single mutation. Brian also discusses the process for licensing a shelved Pfizer asset for development, designing Phase 3 trials that challenge assumptions, the benefits of...
- Aug 10, 202650 min
Cell Therapy Advances And Biotech Leadership With Nkarta's Paul Hastings
We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Paul Hastings, Founding CEO and Board Member at Nkarta, an allogeneic cell therapy developer, talks about building off-the-shelf CAR NK cell therapies for autoimmune disease. Paul is candid about problems with clinical trial infrastructure in the U.S., what it will take to fix trial access (biotechs should actively facilitate patient access to trials and work with community health center...
- Aug 3, 202655 min
A Rescue Model For Shelved Drug Candidates With Annette Bakker, Ph.D. And Andrew Lo, Ph.D.
We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Annette Bakker, Ph.D., CEO at the Children's Tumor Foundation, and Andrew Lo, Ph.D., Finance Professor at MIT's Sloan School of Management and Director of the Laboratory for Financial Engineering, talk about the methods and economics for turning abandoned drug candidates into new therapies for patients. Annette and Andrew share the story of Gomekli, a formerly shelved Pfizer drug candida...
- Jul 27, 202654 min
Using Genetics To Discover New Treatments With Regeneron Genetics Center's Aris Baras, M.D.
We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Aris Baras, M.D., SVP, Head of Regeneron Genetics Center (RGC) and Co-Head of Regeneron Genetic Medicines, talks about using large-scale human genetics to find better drug targets based on "superhuman" variants. Aris explains how multi-omics, linked health records, and AI are helping developers move faster in the clinic and reduce the odds of failure, while also pushing biotech toward ea...
Get Business Of Biotech summaries in your inbox
Free AI-powered daily recaps. Key takeaways, quotes, and mentions — in a 5-minute read.
Get Free Summaries →Free forever for up to 3 podcasts. No credit card required.
You Might Also Like
Listeners also like.
BiggerPockets Business Podcast
Real entrepreneurs share practical advice on starting, growing, and selling businesses, covering hiring, marketing, and raising capital.
Founder's Story
Real founders share raw stories of building, scaling, and leading companies, revealing the grit and purpose behind entrepreneurial success.
Business Daily
A daily exploration of the world of money and work from the BBC.
The Money Mondays
Discusses investments, side hustles, and charity through interviews with entrepreneurs and celebrities in their homes and studios.
The Entrepreneur DNA
Entrepreneurs share lessons on building businesses and personal growth through real experiences and mistakes.
The Best One Yet
Daily business news explained through sharp analysis and witty commentary, delivered in concise 20-minute episodes.
TechSurge: Deep Tech Podcast
Explores emerging technologies, startup challenges, and investment trends through interviews with tech leaders, founders, and investors.
Business Movers
True stories of visionary business leaders and the bold risks, successes, and failures that shaped iconic companies and changed the world.
Right About Now - Legendary Business Advice
Real talk from business founders and entrepreneurs about building companies, lessons learned, and what actually works in real-world ventures.
The Bottom Line
Evan Davis interviews business leaders about major industry challenges, leadership decisions, and the realities of running organizations.
DTC POD: How The Best Brands Are Built
Explores how direct-to-consumer brands are built, from startup to growth, through interviews with founders, marketers, and industry experts.
The Investor's Podcast (We Study Billionaires) - The Investor’s Podcast Network
Analyzes the investment strategies of billionaire investors and explores lessons from legendary financiers on wealth, wisdom, and life.
About Business Of Biotech
The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, regulatory, and commercial challenges you’ll face as you navigate your company from an idea to success in the clinic and beyond. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries.
Customized Recaps
AI-powered recaps with compact key takeaways, quotes, and insights.
Straight to Your Inbox
Get key takeaways from Business Of Biotech in a 5-minute read.
Save Hours Every Week
Stay current on your favorite podcasts without falling behind.
Frequently Asked Questions
What is Podzilla's Business Of Biotech daily summary?
It's a free AI-powered email that summarizes new episodes of Business Of Biotech as soon as they're published. You get the key takeaways, notable quotes, and links & mentions — all in a quick read.
How does the Business Of Biotech podcast summary work?
When a new episode drops, our AI transcribes and analyzes it, then generates a personalized summary tailored to your interests and profession. It's delivered to your inbox every morning.
Is this an official Business Of Biotech product?
No. Podzilla is an independent service that summarizes publicly available podcast content. We're not affiliated with or endorsed by Ben Comer.
Can I get summaries of other podcasts too?
Absolutely! The free plan covers up to 3 podcasts. Upgrade to Pro for 15, or Premium for 50. Browse our full catalog at /podcasts.
How often does Business Of Biotech release new episodes?
Business Of Biotech publishes weekly. Our AI generates a summary within hours of each new episode.
What topics does Business Of Biotech cover?
Business Of Biotech covers topics including Science, Business, Management, Life Sciences. Our AI identifies the specific themes in each episode and highlights what matters most to you.
Start getting Business Of Biotech summaries tomorrow morning.
Free forever for up to 3 podcasts. No credit card required.
Free forever for up to 3 podcasts. No credit card required.